Delivery Order SPE2DR25D2206-SPE2DR26F9LC2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,852.02 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitive, firm fixed-price contract was executed without a set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,376.68 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100 count) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order was awarded on a non-competitive basis and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) valued at $2,469.96, with an ultimate completion date of December 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under the federal procurement process. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a $1,941.48 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of OxyContin ER 40 mg tablets in quantities of 100 units. This firm fixed-price, non-set-aside contract is scheduled for completion by November 13, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,301.66 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on January 10, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside delivery order was placed to the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,837.42 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count packages) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,768.49 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,829.16 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 40 mg tablets (100-count) on January 6, 2026, with completion targeted for January 7, 2026. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The prime contractor, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.05 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9LC2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,273.78 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100 count) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide, including products for the Defense Health Agency and U.S. Coast Guard. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, demonstrating the company's significant role in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/13/26 |